Literature DB >> 15322051

Both expansion of regulatory GR1+ CD11b+ myeloid cells and anergy of T lymphocytes participate in hyporesponsiveness of the lung-associated immune system during acute toxoplasmosis.

Mathieu-Benoît Voisin1, Dominique Buzoni-Gatel, Daniel Bout, Florence Velge-Roussel.   

Abstract

Oral infection with Toxoplasma gondii leads to transient systemic hyporesponsiveness. In this report, we characterized the presence in the lungs of GR1(+) CD11b(+) myeloid cells that have potent nitric oxide-dependent immunoregulatory properties. We also demonstrated the interleukin 2-reversible anergy of both pulmonary CD8(+) and CD4(+) activated T lymphocytes with infection.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15322051      PMCID： PMC517443          DOI： 10.1128/IAI.72.9.5487-5492.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  32 in total

Review 1.  HIV-1 Tat: immunosuppression via TGF-beta1 induction.

Authors:  D Reinhold; S Wrenger; T Kähne; S Ansorge
Journal:  Immunol Today       Date:  1999-08

Review 2.  Implications of Salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive and immunoregulatory molecule.

Authors:  T K Eisenstein
Journal:  Microbes Infect       Date:  2001 Nov-Dec       Impact factor: 2.700

Review 3.  An overview of regulatory T cells.

Authors:  H Groux
Journal:  Microbes Infect       Date:  2001-09       Impact factor: 2.700

4.  Infection of dendritic cells by murine cytomegalovirus induces functional paralysis.

Authors:  D M Andrews; C E Andoniou; F Granucci; P Ricciardi-Castagnoli; M A Degli-Esposti
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

5.  Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation.

Authors:  S A Kusmartsev; Y Li; S H Chen
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

6.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

7.  A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(+) macrophages that suppress naive CD4(+) T cell proliferation via an IFN-gamma and nitric oxide-dependent mechanism.

Authors:  O Atochina; T Daly-Engel; D Piskorska; E McGuire; D A Harn
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

8.  The schistosome oligosaccharide lacto-N-neotetraose expands Gr1(+) cells that secrete anti-inflammatory cytokines and inhibit proliferation of naive CD4(+) cells: a potential mechanism for immune polarization in helminth infections.

Authors:  L I Terrazas; K L Walsh; D Piskorska; E McGuire; D A Harn
Journal:  J Immunol       Date:  2001-11-01       Impact factor: 5.422

9.  Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production.

Authors:  Micheline Lagranderie; Marie-Anne Nahori; Anne-Marie Balazuc; Hélène Kiefer-Biasizzo; Jose-Roberto Lapa e Silva; Geneviève Milon; Gilles Marchal; Boris B Vargaftig
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

10.  Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1(+))CD11b(+ )immature myeloid suppressor cells.

Authors:  Oscar Goñi; Pilar Alcaide; Manuel Fresno
Journal:  Int Immunol       Date:  2002-10       Impact factor: 4.823
View more
  38 in total

Review 1.  Understanding the multiple functions of Gr-1(+) cell subpopulations during microbial infection.

Authors:  Charlotte E Egan; Woraporn Sukhumavasi; Allison L Bierly; Eric Y Denkers
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  Myeloid-derived suppressor cells control microbial sepsis.

Authors:  Marc Derive; Youcef Bouazza; Corentine Alauzet; Sébastien Gibot
Journal:  Intensive Care Med       Date:  2012-05-03       Impact factor: 17.440

3.  Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity.

Authors:  Brian A Norris; Luke S Uebelhoer; Helder I Nakaya; Aryn A Price; Arash Grakoui; Bali Pulendran
Journal:  Immunity       Date:  2013-02-21       Impact factor: 31.745

Review 4.  Recent advances in myeloid-derived suppressor cell biology.

Authors:  Mahmoud Mohammad Yaseen; Nizar Mohammad Abuharfeil; Homa Darmani; Ammar Daoud
Journal:  Front Med       Date:  2020-09-02       Impact factor: 4.592

5.  Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transfer.

Authors:  Jiangao Zhu; Xiaopei Huang; Yiping Yang
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

6.  Tolerance and immune suppression in the tumor microenvironment.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Cell Immunol       Date:  2015-09-30       Impact factor: 4.868

7.  In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells.

Authors:  Marianna Ioannou; Themis Alissafi; Louis Boon; Dimitrios Boumpas; Panayotis Verginis
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

8.  Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency.

Authors:  Kathy A Green; W James Cook; William R Green
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

9.  Reciprocal relationship of T regulatory cells and monocytic myeloid-derived suppressor cells in LP-BM5 murine retrovirus-induced immunodeficiency.

Authors:  Megan A O'Connor; Jennifer L Vella; William R Green
Journal:  J Gen Virol       Date:  2015-08-06       Impact factor: 3.891

Review 10.  Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.

Authors:  Katherine H Parker; Daniel W Beury; Suzanne Ostrand-Rosenberg
Journal:  Adv Cancer Res       Date:  2015-05-12       Impact factor: 6.242
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.